{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:05:55Z","timestamp":1780934755437,"version":"3.54.1"},"reference-count":77,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006329","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T13:35:23Z","timestamp":1169732123000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cessation of medication for people with schizophrenia already stable on chlorpromazine"],"prefix":"10.1002","volume":"2013","author":[{"given":"Muhammad Qutayba","family":"Almerie","sequence":"first","affiliation":[{"name":"Leeds Teaching Hospitals NHS Trust; Department of General Surgery; Beckett Street Leeds UK LS9 7TF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Alkhateeb","sequence":"additional","affiliation":[{"name":"Damascus University; Iskendarieh Street Al Wozara Building NO 28 , 9th floor Damascus Syrian Arab Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adib","family":"Essali","sequence":"additional","affiliation":[{"name":"Modern Psychiatry Hospital; Psychiatry Centre; 27 Al Zahrawi Street Rawda Damascus Syrian Arab Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosam E","family":"Matar","sequence":"additional","affiliation":[{"name":"Northern General Hospital; Department of Trauma and Orthopaedics; Herries Road Sheffield UK S5 7AU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emtithal","family":"Rezk","sequence":"additional","affiliation":[{"name":"Al-Mowasat Hospital; Infectious Diseases Department; 27 Al Zahrawi Street Damascus University Damascus Syrian Arab Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,24]]},"reference":[{"key":"10.1002\/14651858.CD006329-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1192\/bjp.128.5.451","article-title":"A controlled trial of phenothiazine withdrawal in chronic schizophrenic patients","volume":"128","author":"Andrews","year":"1976","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD006329-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0021-9681(64)90075-X","article-title":"Discontinuation or reduction of chemotherapy in chronic schizophrenics","volume":"17","author":"Caffey","year":"1964","journal-title":"Journal of Chronic Diseases"},{"key":"10.1002\/14651858.CD006329-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1176\/ajp.120.6.578","article-title":"Phenothiazine excretion in chronic schizophrenics","volume":"120","author":"Caffey","year":"1963","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006329-BIB0004|cit4","first-page":"522","article-title":"Prolonged withdrawal of chlorpromazine in chronic patients","volume":"23","author":"Freeman Leslie","year":"1962","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD006329-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1176\/ajp.123.2.221","article-title":"Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients","volume":"123","author":"Greenberg","year":"1966","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006329-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/archpsyc.1977.01770140061008","article-title":"Prediction of relapse in schizophrenic outpatients treated by drug and sociotherapy","volume":"34","author":"Goldberg","year":"1977","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006329-BIB0009|cit7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archpsyc.1973.01750310038007","article-title":"Drug and sociotherapy in the aftercare of schizophrenic patients. one-year relapse rates","volume":"28","author":"Hogarty","year":"1973","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006329-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archpsyc.1974.01760170011002","article-title":"Drug and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of non relapsed patients","volume":"31","author":"Hogarty","year":"1974","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006329-BIB0007|cit9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1974.01760170005001","article-title":"Drug and sociotherapy in the aftercare of schizophrenic patients. II two-year relapse rates","volume":"31","author":"Hogarty","year":"1974","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD006329-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/archpsyc.1977.01770150055005","article-title":"Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients","volume":"34","author":"Hogarty","year":"1977","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006329-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1192\/bjp.138.3.271a","article-title":"Phenothiazine withdrawal in schizophrenics in a hostel","volume":"138","author":"Mathur","year":"1981","journal-title":"British Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD006329-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/ajp.124.11.1585","article-title":"A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia","volume":"124","author":"Morton","year":"1968","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006329-BIB0014|cit13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0920-9964(93)90075-T","article-title":"The Clinical relevance of an auditory attention task (PAT) in a longitudinal study of chronic schizophrenia with placebo substitution for chlorpromazine","volume":"10","author":"Pigache","year":"1993","journal-title":"Schizophrenia research"},{"issue":"6","key":"10.1002\/14651858.CD006329-BIB0013|cit14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1042\/cs044028Pa","article-title":"Measurement of drug action in schizophrenia","volume":"44","author":"Pigache","year":"1973","journal-title":"Clinical Science"},{"key":"10.1002\/14651858.CD006329-BIB0015|cit15","first-page":"452","article-title":"Comparison of chlorpromazine and reserpine in maintenance drug therapy","volume":"20","author":"Shawver","year":"1959","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD006329-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.1956.02960380027008","article-title":"Use of chlorpromazine and reserpine in the treatment of emotional disorders","volume":"160","author":"Zeller","year":"1956","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006329-BIB0017|cit17","first-page":"302","article-title":"Behavioral effects of interrupting and resuming tranquillizing medication among schizophrenics","volume":"133","author":"Blackburn","year":"1981","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD006329-BIB0018|cit18","doi-asserted-by":"crossref","unstructured":"Bouchard RH Pourcher E M\u00e9rette C Demers MF Villeneuve J Roy MA Gauthier Y Cliche D Labelle A Maziade M One year follow up of schizophrenic patients treated with risperidone or classical neuroleptics: a prospective, randomized, multicentered open study 11th European College of Neuropsychopharmacology Congress; 1998 Oct 31 - Nov 4; Paris, France 1998","DOI":"10.1016\/S0924-977X(98)80455-0"},{"key":"10.1002\/14651858.CD006329-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-0447.1990.tb05301.x","article-title":"A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation","volume":"358","author":"Chouinard","year":"1990","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD006329-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.148.2.120","article-title":"A randomised controlled trial of prophylactic neuroleptic treatment","volume":"148","author":"Crow","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006329-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005053-196009000-00006","article-title":"Discontinuance of tranquillizers among chronic schizophrenic patients receiving maintenance dosage","volume":"131","author":"Diamond","year":"1960","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"5","key":"10.1002\/14651858.CD006329-BIB0022|cit22","first-page":"321","article-title":"Withdrawal of ataractic medication in schizophrenic patients","volume":"27","author":"Garfield","year":"1966","journal-title":"Diseases of the Nervous System"},{"issue":"2","key":"10.1002\/14651858.CD006329-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00005053-196708000-00008","article-title":"Paranoid and withdrawal symptoms in schizophrenia: differential symptom reduction over time","volume":"145","author":"Goldberg","year":"1967","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD006329-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1176\/ajp.115.5.443","article-title":"Termination of chlorpromazine with schizophrenic patients","volume":"115","author":"Good","year":"1958","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006329-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00005053-195808000-00009","article-title":"Influence of chlorpromazine on certain biochemical variables of chronic male schizophrenics","volume":"127","author":"Mefferd","year":"1958","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD006329-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1176\/ajp.116.10.931","article-title":"Discontinuation of treatment with ataractic drugs. A preliminary report","volume":"116","author":"Gross","year":"1960","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006329-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005053-195809000-00002","article-title":"Chlorpromazine in schizophrenic withdrawal and in the withdrawn schizophrenic","volume":"127","author":"Hine","year":"1958","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"1","key":"10.1002\/14651858.CD006329-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00004714-198402000-00003","article-title":"Pharmacogenic depression among outpatient schizophrenic patients: a failure to substantiate","volume":"4","author":"Hogarty","year":"1984","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006329-BIB0029|cit29","unstructured":"Howanitz EM Pardo M Litwin P Stern RG Wainwright KM FLosonczy M Efficacy of clozapine versus chlorpromazine in geriatric schizophrenia 149th Annual Meeting of the American Psychiatric Association; 1996 Oct 2 - May 9; New York, New York, USA 1996 5947494"},{"issue":"634","key":"10.1002\/14651858.CD006329-BIB0030|cit30","first-page":"302","article-title":"A double blind comparison of thiothixene and a trifluoperazine-chlorpromazine composite in the treatment of chronic schizophrenia","volume":"89","author":"Knight","year":"1979","journal-title":"New Zealand Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD006329-BIB0031|cit31","first-page":"403","article-title":"A double blind evaluation of chlorpromazine versus a combination of perphenazine and amitriptyline","volume":"3","author":"Apella","year":"1967","journal-title":"International Journal of Neuropsychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006329-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0920-9964(97)00034-0","article-title":"Immediate effects of chlorpromazine and perphenazine following neuroleptic washout on word association of schizophrenic patients","volume":"26","author":"Levine","year":"1997","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006329-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00005053-195808000-00009","article-title":"Influence of chlorpromazine on certain biochemical variables of chronic male schizophrenics","volume":"127","author":"Mefferd","year":"1958","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"5","key":"10.1002\/14651858.CD006329-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/070674376601100507","article-title":"Abrupt withdrawal of chlorpromazine and thioridazine from schizophrenic in-patients","volume":"11","author":"Melnyk","year":"1966","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD006329-BIB0035|cit35","unstructured":"Montero E Thioridazine compared with a combination of chlorpromazine and trifluoperazine hydrochloride in schizophrenic patients 5th World Congress of Psychiatry; 1971 Nov 28 - Dec 4; Mexico City, Mexico 1971 433 4596671"},{"key":"10.1002\/14651858.CD006329-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1176\/ajp.115.5.449","article-title":"Specific behavioural changes produced by chlorpromazine in chronic schizophrenia","volume":"115","author":"Moss","year":"1958","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006329-BIB0037|cit37","unstructured":"Pai YM Yu SC Lin CC Risperidone in reducing tardive dyskinesia: a double-blind, placebo-controlled study 154th Annual Meeting of the American Psychiatric Association; 2001 May 5-10; New Orleans, Louisiana, USA Marathon Multimedia 2001 98017426"},{"issue":"1","key":"10.1002\/14651858.CD006329-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0920-9964(93)90076-U","article-title":"Effects of placebo, orphenadrine, and rising doses of chlorpromazine, on PAT performance in chronic schizophrenia. A two year longitudinal study","volume":"10","author":"Pigache","year":"1993","journal-title":"Schizophrenia Research"},{"issue":"7","key":"10.1002\/14651858.CD006329-BIB0039|cit39","first-page":"327","article-title":"Lithium in treatment and prevention of effective disorder: a VA NIMH collaborative study","volume":"35","author":"Pokorny","year":"1974","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD006329-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1176\/ajp.112.11.937","article-title":"The effect of chlorpromazine on the return rate of 250 patients released from the Rochester State Hospital","volume":"112","author":"Pollack","year":"1956","journal-title":"American Journal of Psychiatry"},{"issue":"523","key":"10.1002\/14651858.CD006329-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1192\/bjp.115.523.679","article-title":"Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication","volume":"115","author":"Prien","year":"1968","journal-title":"British Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD006329-BIB0042|cit42","first-page":"739","article-title":"Indications for high dose chlorpromazine therapy in chronic schizophrenia","volume":"31","author":"Prien","year":"1970","journal-title":"Diseases of the Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD006329-BIB0043|cit43","first-page":"151","article-title":"A comparison of thioridazine, trifluoperazine, chlorpromazine, and placebo: a double-blind controlled study on the treatment of chronic hospitalized, schizophrenic patients","volume":"22","author":"Schiele","year":"1961","journal-title":"Journal of Clinical and Experimental Psychopathology"},{"key":"10.1002\/14651858.CD006329-BIB0044|cit44","unstructured":"Slotnick VB Management of the acutely agitated psychiatric patient with parental neuroleptics: the comparative symptom effectiveness profiles of haloperidol and chlorpromazine 5th World Congress of Psychiatry; 1971 Nov 28 - Dec 4; Mexico City, Mexico 1971 531 215095"},{"key":"10.1002\/14651858.CD006329-BIB0045|cit45","first-page":"11","article-title":"Maintenance phenothiazines in aftercare of schizophrenic patients","volume":"2","author":"Troshinsky","year":"1962","journal-title":"Pennsylvania Psychiatric Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD006329-BIB0046|cit46","first-page":"62","article-title":"Pimozide versus chlorpromazine in chronic schizophrenia - a 52 week double blind study of maintenance therapy","volume":"43","author":"Wilson","year":"1982","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006329-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00431102","article-title":"Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses","volume":"73","author":"Wode-Helgodt","year":"1981","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD006329-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/archpsyc.55.8.754","article-title":"Randomised controlled trials in Archives of General Psychiatry (1959-1995): a prevalence study","volume":"55","author":"Ahmed","year":"1998","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006329-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006329-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD006329-BIB0051|cit51","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD006329-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1943-278X.1992.tb01040.x","article-title":"Schizophrenia - a high-risk factor for suicide: clues to risk reduction","volume":"22","author":"Caldwell","year":"1992","journal-title":"Suicide and life-threatening behavior"},{"key":"10.1002\/14651858.CD006329-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006329-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006329-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1192\/bjp.146.5.474","article-title":"Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine\/placebo trial. III. Relapse postponement or relapse prevention? The implications for long-term outcome","volume":"146","author":"Curson","year":"1985","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006329-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1176\/ajp.132.12.1237","article-title":"Overview: maintenance therapy in psychiatry - I. Schizophrenia","volume":"132","author":"Davis","year":"1975","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006329-BIB0057|cit57","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Abstracts of 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa 2000"},{"key":"10.1002\/14651858.CD006329-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD006329-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donne","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD006329-BIB0060|cit60","first-page":"3","article-title":"Seventeen years in the life of a depot neuroleptic clinic - an audit study of schizophrenia and other psychosis","volume":"6","author":"Essali","year":"1993","journal-title":"British Journal of Medical Economics"},{"key":"10.1002\/14651858.CD006329-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archpsyc.1995.03950150005001","article-title":"Neuroleptic withdrawal in schizophrenic patients","volume":"52","author":"Gilbert","year":"1995","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006329-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006329-BIB0063|cit63","volume-title":"ECD EU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD006329-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD006329-BIB0065|cit65","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] Cochrane Database of Systematic Reviews 2005"},{"key":"10.1002\/14651858.CD006329-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1192\/bjp.165.6.787","article-title":"Post-mortem antipsychotic drug concentrations and unexplained deaths","volume":"165","author":"Jusic","year":"1994","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006329-BIB0067|cit67","first-page":"19","volume-title":"The Multidimensional Scale for Rating Psychiatric Patients","author":"Lorr","year":"1953"},{"key":"10.1002\/14651858.CD006329-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"issue":"15","key":"10.1002\/14651858.CD006329-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006329-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archpsyc.1964.01720210028005","article-title":"Phenothiazine treatment in schizophrenia","volume":"10","author":"National Institute of Mental Health","year":"1964","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006329-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD006329-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA: Journal of American Medical Association"},{"key":"10.1002\/14651858.CD006329-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S026418010000059X","article-title":"The Natural History of Schizophrenia: a five-year follow-up study of outcome prediction in a representative sample of schizophrenics.","volume":"15 (Suppl.)","author":"Shepherd","year":"1989","journal-title":"Psychological Medicine. Monograph supplement"},{"key":"10.1002\/14651858.CD006329-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/bmj.317.7167.1181","article-title":"Content and quality of 2000 controlled trials in schizophrenia over 50 years","volume":"317","author":"Thornley","year":"1998","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD006329-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000284.pub2","article-title":"Chlorpromazine versus placebo for schizophrenia","author":"Thornley","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD006329-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD006329-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1192\/bjp.107.450.862","article-title":"A simple and reliable sub-classification of chronic schizophrenia.","volume":"107","author":"Wing","year":"1961","journal-title":"The Journal of Mental Science"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T18:32:51Z","timestamp":1725733971000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006329"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,1,24]]},"references-count":77,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006329","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,24]]}}}